BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15944139)

  • 21. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
    Steiner AZ; Hodis HN; Lobo RA; Shoupe D; Xiang M; Mack WJ
    Menopause; 2005; 12(6):728-33. PubMed ID: 16278616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women.
    Archer JS; Love-Geffen TE; Herbst-Damm KL; Swinney DA; Chang JR
    Menopause; 2006; 13(3):528-37. PubMed ID: 16735951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menopausal estrogen therapy predicts better nocturnal oxyhemoglobin saturation.
    Saaresranta T; Polo-Kantola P; Virtanen I; Vahlberg T; Irjala K; Polo O
    Maturitas; 2006 Oct; 55(3):255-63. PubMed ID: 16675167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women.
    Hudson AG; Gierach GL; Modugno F; Simpson J; Wilson JW; Evans RW; Vogel VG; Weissfeld JL
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):680-7. PubMed ID: 18349287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral or trandsdermanl hormone replacement therapy reduces interleukine-6 levels].
    Saucedo García R; Basurto Acevedo L; Rico Rosillo G; Galván RE; Zárate Treviño A
    Ginecol Obstet Mex; 2006 Mar; 74(3):133-8. PubMed ID: 16886754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women.
    Maffei S; Mercuri A; Zucchelli GC; Vassalle C
    Int J Cardiol; 2006 Feb; 107(2):194-9. PubMed ID: 16412796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nocturnal transcutaneous carbon dioxide tension in postmenopausal estrogen users and non-users.
    Aittokallio J; Hiissa J; Saaresranta T; Polo-Kantola P; Aittokallio T; Polo O
    Menopause Int; 2009 Sep; 15(3):107-12. PubMed ID: 19723680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.
    Karara AH; Hanes V; Alonso A; Ni P; Poola N; Silang R; Blode H; Preston RA
    J Clin Pharmacol; 2007 Oct; 47(10):1292-302. PubMed ID: 17906162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of oestradiol and oestroprogestin on erythrocyte antioxidative enzyme system activity in postmenopausal women.
    Bednarek-Tupikowska G; Tworowska U; Jedrychowska I; Radomska B; Tupikowski K; Bidzinska-Speichert B; Milewicz A
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):463-8. PubMed ID: 16584521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
    Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks.
    Gupta P; Harte A; Sturdee DW; Sharma A; Barnett AH; Kumar S; McTernan PG
    Climacteric; 2008 Oct; 11(5):364-72. PubMed ID: 18781480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
    Preston RA; Norris PM; Alonso AB; Ni P; Hanes V; Karara AH
    Menopause; 2007; 14(3 Pt 1):408-14. PubMed ID: 17224857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of estrogen receptor and circulating estradiol levels in pre- and postmenopausal women with periodontal disease.
    Karthik SJ; Arun KV; Sudarsan S; Talwar A; James JR
    J Int Acad Periodontol; 2009 Jul; 11(3):202-5. PubMed ID: 19753797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of estrogen therapy on insulin resistance and plasminogen activator inhibitor type 1 concentrations in postmenopausal women.
    Saucedo R; Basurto L; Zarate A; Martínez C; Hernandez M; Galván R
    Gynecol Obstet Invest; 2007; 64(2):61-4. PubMed ID: 17264514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
    Sweeney AT; Tangpricha V; Weinberg J; Malabanan AO; Chimeh FN; Holick MF
    Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin dilemma in postmenopausal women: is it low or high?
    Haliloglu B; Benli Aksungar F; Ilter E; Temelli Akin F; Mutlu N; Peker H; Ozden S
    Maturitas; 2008 Jun; 60(2):148-52. PubMed ID: 18554829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial.
    Crandall C; Palla S; Reboussin B; Hu P; Barrett-Connor E; Reuben D; Greendale G
    J Womens Health (Larchmt); 2006; 15(1):14-23. PubMed ID: 16417414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption of vaginal estrogen cream during sexual intercourse: a prospective, randomized, controlled trial.
    Hurst BS; Jones AI; Elliot M; Marshburn PB; Matthews ML
    J Reprod Med; 2008 Jan; 53(1):29-32. PubMed ID: 18251358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.